Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

The role of brain glutamatergic system in the neuroendocrine regulation of cytochrome P450 expression and activity in the liver

2016/23/B/NZ7/02283

Keywords:

brain glutamatergic system ionotropic and metabotropic receptors hypothalamus pituitary neuroendocrine regulation liver cytochrome P450

Descriptors:

  • NZ7_14: Pharmacy, pharmacotherapy, pharmacology

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

woj. małopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Władysława Daniel 

Number of co-investigators in the project: 6

Call: OPUS 12 - announced on 2016-09-15

Amount awarded: 1 290 799 PLN

Project start date (Y-m-d): 2017-07-26

Project end date (Y-m-d): 2022-07-25

Project duration:: 60 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Wielofunkcyjny czytnik płytek (117 000 PLN)
  2. Zamrażarka niskotemperaturowa (-80 st. C) (62 000 PLN)

Information in the final report

  • Publication in academic press/journals (3)
  • Articles in post-conference publications (5)
  1. The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver .
    Authors:
    Bromek E, Haduch A, Rysz M, Jastrzębska J, Pukło R, Wójcikowska O, Danek PJ, Daniel WA
    Academic press:
    Pharmaceutics (rok: 2021, tom: 13, strony: 1643), Wydawca: MDPI (Multidisciplinary Digital Publishing Institute, Basel Switzerland)
    Status:
    Published
    DOI:
    10.3390/pharmaceutics13101643 - link to the publication
  2. The effect of the selective NMDA receptor GluN2B subunit antagonist CP-101,606 on cytochrome P450 2D (CYP2D) expression and activity in the rat liver and brain
    Authors:
    Anna Haduch, Ewa Bromek, Renata Pukło, Joanna Jastrzębska, Przemysław J. Danek and Władysława A. Daniel
    Academic press:
    International Journal of Molecular Sciences (rok: 2022, tom: 23, strony: 45304), Wydawca: MDPI (Multidisciplinary Digital Publishing Institute, Basel Switzerland)
    Status:
    Published
    DOI:
    10.3390/ijms232213746 - link to the publication
  3. The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions
    Authors:
    Władysława A. Daniel, Ewa Bromek, Przemysław J. Danek and Anna Haduch
    Academic press:
    Biochemical Pharmacology (rok: 2022, tom: 199, strony: 115006), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bcp.2022.115006 - link to the publication
  1. The effect of the NMDA receptor GluN2B subunit antagonist CP-101,606 on brain and liver cytochrome P450 2D (CYP2D).
    Authors:
    Daniel W.A., Haduch A., Bromek E., Jastrzębska J., Pukło R.
    Conference:
    34th ECNP Congress Hybrid, Lisbon, Portugal (rok: 2021, ), Wydawca: Elsevier, European Neuropsychopharmacology 53 (Suppl. 1)
    Data:
    konferencja 2-5.10.2021
    Status:
    Published
  2. The effect of the glutamate system on liver cytochrome P450 expression and activity.
    Authors:
    Bromek E., Haduch A., Rysz M., Jastrzębska J., Pukło R., Daniel W.A.
    Conference:
    34th ECNP Congress Hybrid, Lisbon, Portugal (rok: 2021, ), Wydawca: Elsevier, European Neuropsychopharmacology, 53, Suppl. 1
    Data:
    konferencja 2-5.10.2021
    Status:
    Published
  3. The effect of short- and long-termtreatment with NMDA receptor antagonist on the activity of cytochrome P450 in rat liver
    Authors:
    Wójcikowska O., Bromek E., Haduch A., Rysz M., Pukło R., Daniel W.A.
    Conference:
    NEURONUS 2020 IBRO Neuroscience Forum (rok: 2020, ), Wydawca: konferencja on-line
    Data:
    konferencja 8-11.12.
    Status:
    Published
  4. The expression of cytochrome P450 in the liver is regulated by the GluN2B subunit NMDA receptor antagonist CP-101,606.
    Authors:
    Bromek E., Haduch A., Rysz M., Pukło R., Daniel W.A.
    Conference:
    International Conference on cytochrome P450 (ICCP450) (rok: 2019, ), Wydawca: International Conference on cytochrome P450 (ICCP450)
    Data:
    konferencja 23-27.06.
    Status:
    Published
  5. The positive allosteric modulator of mGlu5 receptor (VU 0360172), but not the mGlu2/3 receptor agonist (LY354740) affects liver cytochrome P450.
    Authors:
    Daniel W.A., Bromek E., Haduch A., Pukło R., Kot M.
    Conference:
    International Conference on cytochrome P450 (ICCP450) (rok: 2019, ), Wydawca: International Conference on cytochrome P450 (ICCP450)
    Data:
    konferencja 23-27.06.
    Status:
    Published

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy